These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 18490082)
1. Laboratory methods for assessing vaccine potency retained in aerosol outputs from nebulizers: application to World Health Organization measles aerosol project. Cohen BJ; Parry RP; Andrews N; Bennett AM; Dennis JH Vaccine; 2008 Jun; 26(27-28):3534-9. PubMed ID: 18490082 [TBL] [Abstract][Full Text] [Related]
2. Aerosolized measles and measles-rubella vaccines induce better measles antibody booster responses than injected vaccines: randomized trials in Mexican schoolchildren. Bennett JV; Fernandez de Castro J; Valdespino-Gomez JL; Garcia-Garcia Mde L; Islas-Romero R; Echaniz-Aviles G; Jimenez-Corona A; Sepulveda-Amor J Bull World Health Organ; 2002; 80(10):806-12. PubMed ID: 12471401 [TBL] [Abstract][Full Text] [Related]
3. Immunogenicity of aerosol measles vaccine given as the primary measles immunization to nine-month-old Mexican children. Wong-Chew RM; Islas-Romero R; García-García Mde L; Beeler JA; Audet S; Santos-Preciado JI; Gans H; Lew-Yasukawa L; Maldonado YA; Arvin AM; Valdespino-Gómez JL Vaccine; 2006 Jan; 24(5):683-90. PubMed ID: 16154241 [TBL] [Abstract][Full Text] [Related]
4. [Titration and stability tests for antimeasles vaccine]. Ayala-González M Bol Med Hosp Infant Mex; 1990 Jul; 47(7):512-5. PubMed ID: 2206418 [TBL] [Abstract][Full Text] [Related]
6. Response to different measles vaccine strains given by aerosol and subcutaneous routes to schoolchildren: a randomised trial. Dilraj A; Cutts FT; de Castro JF; Wheeler JG; Brown D; Roth C; Coovadia HM; Bennett JV Lancet; 2000 Mar; 355(9206):798-803. PubMed ID: 10711928 [TBL] [Abstract][Full Text] [Related]
7. Aerosol measles vaccination in macaques: preclinical studies of immune responses and safety. de Swart RL; Kuiken T; Fernandez-de Castro J; Papania MJ; Bennett JV; Valdespino JL; Minor P; Witham CL; Yüksel S; Vos H; van Amerongen G; Osterhaus AD Vaccine; 2006 Sep; 24(40-41):6424-36. PubMed ID: 16934375 [TBL] [Abstract][Full Text] [Related]
8. Induction of cellular and humoral immunity after aerosol or subcutaneous administration of Edmonston-Zagreb measles vaccine as a primary dose to 12-month-old children. Wong-Chew RM; Islas-Romero R; García-García Mde L; Beeler JA; Audet S; Santos-Preciado JI; Gans H; Lew-Yasukawa L; Maldonado YA; Arvin AM; Valdespino-Gómez JL J Infect Dis; 2004 Jan; 189(2):254-7. PubMed ID: 14722890 [TBL] [Abstract][Full Text] [Related]
9. Potency status and efficacy of measles vaccine administered in Nigeria: a case study of three EPI centres in Lagos, Nigeria. Omilabu SA; Oyefolu AO; Ojo OO; Audu RA Afr J Med Med Sci; 1999; 28(3-4):209-12. PubMed ID: 11205835 [TBL] [Abstract][Full Text] [Related]
10. [Measles vaccination by the aerosol method in Mexico]. Fernández-de Castro J; Kumate-Rodríguez J; Sepúlveda J; Ramírez-Isunza JM; Valdespino-Gómez JL Salud Publica Mex; 1997; 39(1):53-60. PubMed ID: 9092098 [TBL] [Abstract][Full Text] [Related]
11. Measles vaccination of macaques by dry powder inhalation. de Swart RL; LiCalsi C; Quirk AV; van Amerongen G; Nodelman V; Alcock R; Yüksel S; Ward GH; Hardy JG; Vos H; Witham CL; Grainger CI; Kuiken T; Greenspan BJ; Gard TG; Osterhaus AD Vaccine; 2007 Jan; 25(7):1183-90. PubMed ID: 17084489 [TBL] [Abstract][Full Text] [Related]
12. Plaque reduction neutralization test for measles antibodies: Description of a standardised laboratory method for use in immunogenicity studies of aerosol vaccination. Cohen BJ; Audet S; Andrews N; Beeler J; Vaccine; 2007 Dec; 26(1):59-66. PubMed ID: 18063236 [TBL] [Abstract][Full Text] [Related]
13. Estimation of the number of infectious measles viruses in live virus vaccines using quantitative real-time PCR. Schalk JA; van den Elzen C; Ovelgönne H; Baas C; Jongen PM J Virol Methods; 2004 May; 117(2):179-87. PubMed ID: 15041215 [TBL] [Abstract][Full Text] [Related]
14. Comparison of Edmonston-Zagreb and Schwarz strains of measles vaccine given by aerosol or subcutaneous injection. Khanum S; Uddin N; Garelick H; Mann G; Tomkins A Lancet; 1987 Jan; 1(8525):150-3. PubMed ID: 2879981 [TBL] [Abstract][Full Text] [Related]
15. Attenuation and characterisation of Edmonston-Zagreb measles virus. Ikić D; Juzbasić M; Beck M; Hrabar A; Cimbur-Schreiber T Ann Immunol Hung; 1972; 16(0):175-81. PubMed ID: 4679646 [No Abstract] [Full Text] [Related]
16. Current progress in pulmonary delivery of measles vaccine. Griffin DE Expert Rev Vaccines; 2014 Jun; 13(6):751-9. PubMed ID: 24837839 [TBL] [Abstract][Full Text] [Related]
17. How many infective viral particles are necessary for successful mass measles immunization by aerosol? Coates AL; Tipples G; Leung K; Gray M; Louca E; Vaccine; 2006 Mar; 24(10):1578-85. PubMed ID: 16266775 [TBL] [Abstract][Full Text] [Related]
18. Dry powder measles vaccine: particle deposition, virus replication, and immune response in cotton rats following inhalation. Kisich KO; Higgins MP; Park I; Cape SP; Lindsay L; Bennett DJ; Winston S; Searles J; Sievers RE Vaccine; 2011 Jan; 29(5):905-12. PubMed ID: 20974303 [TBL] [Abstract][Full Text] [Related]
19. Alternative routes of measles immunization: a review. Cutts FT; Clements CJ; Bennett JV Biologicals; 1997 Sep; 25(3):323-38. PubMed ID: 9325001 [TBL] [Abstract][Full Text] [Related]